{"cik":1129928,"taxonomy":"us-gaap","tag":"LiabilitiesCurrent","label":"Liabilities, Current","description":"Total obligations incurred as part of normal operations that are expected to be paid during the following twelve months or within one business cycle, if longer.","entityName":"ONCOLYTICS BIOTECH INC.","units":{"USD":[{"end":"2024-12-31","val":4885000,"accn":"0001129928-26-000020","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-30","frame":"CY2024Q4I"},{"end":"2025-12-31","val":6101000,"accn":"0001129928-26-000020","fy":2025,"fp":"FY","form":"10-K","filed":"2026-03-30"},{"end":"2025-12-31","val":6101000,"accn":"0001129928-26-000033","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-14"},{"end":"2025-12-31","val":6101000,"accn":"0001129928-26-000051","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-12","frame":"CY2025Q4I"},{"end":"2026-03-31","val":5423000,"accn":"0001129928-26-000033","fy":2026,"fp":"Q1","form":"10-Q","filed":"2026-05-14","frame":"CY2026Q1I"},{"end":"2026-06-30","val":5225000,"accn":"0001129928-26-000051","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-08-12","frame":"CY2026Q2I"}]}}